He Helped Spare Millions From COVID. Now He's Fighting Other Killer Viruses.
Jason McLellan’s groundbreaking research is changing the way vaccines are developed—including those for another formidable pathogen, RSV.
Source: texasmonthly.com
Daniel Wrapp News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Daniel Wrapp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Daniel Wrapp Today - Breaking & Trending Today
Creator of Breakthrough Coronavirus Technology to Receive Inaugural McGuire Prize
$100,000 prize to be awarded at Dartmouth on May 13
Source: dartmouth.edu
The story behind the blistering speed of COVID vaccine development
Posted: May 02, 2021 6:00 AM NT | Last Updated: May 2 comments Jason McLellan in his lab at the University of Texas at Austin in February 2020. Many of the COVID vaccines that have been developed used Dr. McLellan’s research. (College of Natural Sciences, University of Texas at Austin) This column is an instalment in our series , in which cultural historian Ainsley Hawthorn examines the issues of COVID-19 through the lens of the past. Past pandemics can bring our experiences with COVID-19 into focus, whether by reassuring us that we're far from the first people to face a serious outbreak...
Source: cbc.ca
The FINANCIAL - Human Trials Begin for a Low-Cost COVID-19 Vaccine to Extend Global Access
Share This The FINANCIAL -- In a major boost to efforts to combat COVID-19 globally, a vaccine that recently entered human trials in Vietnam and Thailand, and is slated for a clinical study in Brazil, holds promise for affordable vaccine manufacturing in countries currently dependent on imported vaccines. The vaccine is the result of a partnership between The University of Texas at Austin, the Icahn School of Medicine at Mount Sinai in New York and global partners interested in advancing the supply of affordable vaccines to address the pandemic. The vaccine, NDV-HXP-S, can be stored at 2-8...
Source: finchannel.com
Tiny antibodies naturally generated by llamas can be effective against COVID-19
Tiny antibodies naturally generated by llamas can be effective against COVID-19 As the fight against COVID-19 continues, scientists have turned to an unlikely source for a potentially effective treatment: tiny antibodies naturally generated by llamas. While the world has welcomed the news of multiple vaccines against COVID-19, the search for effective treatments for those who contract the virus is ongoing. Now scientists are looking to what might seem to be an unlikely source: the South American llama. Researchers are using the ultrabright X-rays of the Advanced Photon Source (APS), a U.S. De...
Source: news-medical.net